Logo image of CXT

CRANE NXT CO (CXT) Stock Fundamental Analysis

NYSE:CXT - New York Stock Exchange, Inc. - US2244411052 - Common Stock - Currency: USD

58.12  -1.15 (-1.94%)

After market: 58.12 0 (0%)

Fundamental Rating

5

Overall CXT gets a fundamental rating of 5 out of 10. We evaluated CXT against 124 industry peers in the Electronic Equipment, Instruments & Components industry. CXT has an excellent profitability rating, but there are concerns on its financial health. CXT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CXT was profitable.
In the past year CXT had a positive cash flow from operations.
In the past 5 years CXT has always been profitable.
Each year in the past 5 years CXT had a positive operating cash flow.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

CXT has a better Return On Assets (7.71%) than 85.00% of its industry peers.
CXT has a better Return On Equity (17.29%) than 87.50% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.96%, CXT belongs to the top of the industry, outperforming 84.17% of the companies in the same industry.
CXT had an Average Return On Invested Capital over the past 3 years of 12.77%. This is above the industry average of 8.95%.
Industry RankSector Rank
ROA 7.71%
ROE 17.29%
ROIC 10.96%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)12.77%
ROIC(5y)10.01%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 12.38%, CXT belongs to the top of the industry, outperforming 89.17% of the companies in the same industry.
CXT's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 18.76%, CXT belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.
In the last couple of years the Operating Margin of CXT has declined.
CXT's Gross Margin of 44.73% is fine compared to the rest of the industry. CXT outperforms 77.50% of its industry peers.
In the last couple of years the Gross Margin of CXT has remained more or less at the same level.
Industry RankSector Rank
OM 18.76%
PM (TTM) 12.38%
GM 44.73%
OM growth 3Y-2.89%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

CXT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CXT has been increased compared to 1 year ago.
CXT has a worse debt/assets ratio than last year.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

The Debt to FCF ratio of CXT is 4.45, which is a neutral value as it means it would take CXT, 4.45 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CXT (4.45) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.70 indicates that CXT is somewhat dependend on debt financing.
The Debt to Equity ratio of CXT (0.70) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 4.45
Altman-Z N/A
ROIC/WACC1.31
WACC8.34%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CXT has a Current Ratio of 1.14. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
CXT has a Current ratio of 1.14. This is amonst the worse of the industry: CXT underperforms 92.50% of its industry peers.
A Quick Ratio of 0.88 indicates that CXT may have some problems paying its short term obligations.
The Quick ratio of CXT (0.88) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.88
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.40% over the past year.
Measured over the past years, CXT shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.61% on average per year.
Looking at the last year, CXT shows a small growth in Revenue. The Revenue has grown by 6.86% in the last year.
CXT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.39% yearly.
EPS 1Y (TTM)2.4%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%21.21%
Revenue 1Y (TTM)6.86%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%11.82%

3.2 Future

The Earnings Per Share is expected to grow by 6.80% on average over the next years.
The Revenue is expected to grow by 19.25% on average over the next years. This is quite good.
EPS Next Y0.91%
EPS Next 2Y6.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.06%
Revenue Next 2Y4.13%
Revenue Next 3Y19.25%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.61, CXT is valued correctly.
Based on the Price/Earnings ratio, CXT is valued cheaply inside the industry as 90.83% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 29.63. CXT is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 13.49, CXT is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 87.50% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CXT to the average of the S&P500 Index (22.68), we can say CXT is valued slightly cheaper.
Industry RankSector Rank
PE 13.61
Fwd PE 13.49
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CXT indicates a somewhat cheap valuation: CXT is cheaper than 80.00% of the companies listed in the same industry.
75.00% of the companies in the same industry are more expensive than CXT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.7
EV/EBITDA 10.29
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CXT does not grow enough to justify the current Price/Earnings ratio.
CXT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)14.97
PEG (5Y)N/A
EPS Next 2Y6.8%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

CXT has a Yearly Dividend Yield of 1.15%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.92, CXT pays a better dividend. On top of this CXT pays more dividend than 89.17% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.29, CXT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.15%

5.2 History

The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CXT pays out 19.88% of its income as dividend. This is a sustainable payout ratio.
CXT's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP19.88%
EPS Next 2Y6.8%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (2/21/2025, 8:11:32 PM)

After market: 58.12 0 (0%)

58.12

-1.15 (-1.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners87.63%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner Change4.53%
Market Cap3.32B
Analysts83.64
Price Target92.24 (58.71%)
Short Float %8.46%
Short Ratio10.17
Dividend
Industry RankSector Rank
Dividend Yield 1.15%
Yearly Dividend0.64
Dividend Growth(5Y)6.42%
DP19.88%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-28 2025-02-28 (0.17)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.23%
Min EPS beat(2)-1.06%
Max EPS beat(2)0.6%
EPS beat(4)2
Avg EPS beat(4)-0.05%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.6%
EPS beat(8)6
Avg EPS beat(8)7.74%
EPS beat(12)9
Avg EPS beat(12)6.93%
EPS beat(16)13
Avg EPS beat(16)11.75%
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-2.54%
Max Revenue beat(2)1.8%
Revenue beat(4)1
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)1.8%
Revenue beat(8)4
Avg Revenue beat(8)0.92%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.32%
PT rev (3m)-0.48%
EPS NQ rev (1m)0.56%
EPS NQ rev (3m)0.76%
EPS NY rev (1m)0.12%
EPS NY rev (3m)0.1%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 13.61
Fwd PE 13.49
P/S 2.24
P/FCF 19.7
P/OCF 15.52
P/B 3.12
P/tB N/A
EV/EBITDA 10.29
EPS(TTM)4.27
EY7.35%
EPS(NY)4.31
Fwd EY7.41%
FCF(TTM)2.95
FCFY5.08%
OCF(TTM)3.74
OCFY6.44%
SpS26
BVpS18.62
TBVpS-5.44
PEG (NY)14.97
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.71%
ROE 17.29%
ROCE 15.29%
ROIC 10.96%
ROICexc 11.93%
ROICexgc 45.27%
OM 18.76%
PM (TTM) 12.38%
GM 44.73%
FCFM 11.35%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)12.77%
ROIC(5y)10.01%
ROICexc(3y)14.43%
ROICexc(5y)11.37%
ROICexgc(3y)55.78%
ROICexgc(5y)40.43%
ROCE(3y)17.66%
ROCE(5y)13.69%
ROICexcg growth 3Y33.9%
ROICexcg growth 5YN/A
ROICexc growth 3Y20.37%
ROICexc growth 5YN/A
OM growth 3Y-2.89%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 4.45
Debt/EBITDA 2.05
Cap/Depr 52.3%
Cap/Sales 3.05%
Interest Coverage 250
Cash Conversion 58.55%
Profit Quality 91.64%
Current Ratio 1.14
Quick Ratio 0.88
Altman-Z N/A
F-Score4
WACC8.34%
ROIC/WACC1.31
Cap/Depr(3y)39.82%
Cap/Depr(5y)33.75%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.89%
Profit Quality(3y)120.27%
Profit Quality(5y)131.76%
High Growth Momentum
Growth
EPS 1Y (TTM)2.4%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%21.21%
EPS Next Y0.91%
EPS Next 2Y6.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.86%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%11.82%
Revenue Next Year2.06%
Revenue Next 2Y4.13%
Revenue Next 3Y19.25%
Revenue Next 5YN/A
EBIT growth 1Y-2.92%
EBIT growth 3Y0.41%
EBIT growth 5YN/A
EBIT Next Year21.38%
EBIT Next 3Y13.22%
EBIT Next 5YN/A
FCF growth 1Y-31.2%
FCF growth 3Y-13.25%
FCF growth 5YN/A
OCF growth 1Y-22.51%
OCF growth 3Y-8.23%
OCF growth 5YN/A